{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:58:30Z","timestamp":1773381510525,"version":"3.50.1"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:p>Objectives. Taking into account that genetic predisposition, marked by human leukocyte antigen (HLA) class I and II genes, augments the probability of developing an autoimmune disorder after a triggering vaccination, as largely debated, we investigated the frequency of autoantibody production after recombinant hepatitis B vaccine (rHBv) in 6-year-old children immunized at birth to evaluate an association between autoimmune disorders and hepatitis B virus vaccination.<\/jats:p>\n               <jats:p>Methods. We investigated the presence of autoantibodies in 210 6-year-old children who were immunized at birth with rHBv: 200 showed anti-hepatitis B surface antigen concentrations \u226510 mUI\/mL at seroconversion (responders), and 10 were nonresponders. Data were compared with those obtained in 109 unvaccinated children. All participants were screened for the presence of antinuclear antibodies (ANAs), anti-DNA, antimitochondrial, anti-liver\/kidney microsomal, antireticulin, anti-smooth muscle (SMA), and antiribosomal antibodies. All participants were also screened for the presence of antithyroid antibodies, such as antithyroglobulin and antiperoxidase, and for antibodies found in type 1 diabetes, such as tyrosine phosphatase (IA-2A) and glutamic acid decarboxylase (GADA). HLA typing was extended to all 10 nonresponders.<\/jats:p>\n               <jats:p>Results. Autoantibodies were found in 16 of the 200 responders: ANAs were found in 12 (6%), smooth muscle antibodies were found in 4 (2.0%), and antireticulin antibodies and endomysial antibodies were found in 1 girl with ANAs. Antithyroid antibodies, IA-2A, and GADA were not present in any of the participants. No significant difference was found in the frequency of autoantibodies between vaccinated and control children. Three of the 10 nonresponder children were SMA-positive (30% vs 2% of responders); they also carried the supratype HLA-C4AQ0,DRB1*0301,DQB1*02. A family history for autoimmune disorders was present in 3 (18%; 95% confidence interval [CI]: 4.0%\u201345.6%) of the 16 responder infants with autoantibodies, in 15 (8.4%; 95% CI: 4.6%\u201313.1%) of responder children without autoantibodies, and in 1 (10%) of the 10 nonsreponder children.<\/jats:p>\n               <jats:p>Conclusions. From our data, vaccination with rHBv given during the neonatal period does not seem to increase autoantibody production in a 6-year-old children. Autoantibodies, referred to as natural autoantibodies, can be found in healthy participants, but their significance is unclear. These autoantibodies often cross-react with bacteria or tumor antigens, suggesting their importance in innate immunity. It has been demonstrated in an animal model that self-antigen can promote B-cell accumulation, and that a significant proportion of natural autoantibodies is the product of this self-antigen- dependent process. Consequently, it has been speculated that self-antigens play a positive role in recruiting B cells as a part of innate immunity, but this process carries a potential risk for unregulated growth.<\/jats:p>\n               <jats:p>Spreading of the immune response is a common theme in organ-specific and systemis autoimmune diseases, and this could be initiated by exogenous agents, in genetically susceptible hosts, owing to molecular mimicry of natural antigen. Moreover, 3 (18%) of the 16 children who had autoantibodies had a family history of autoimmume diseases. Thus, it is apparent that susceptibility to autoimmunity is determined by genetic factors rather than by vaccine challenge. Among all the children considered, only 1 girl (0.5%) developed celiac disease, reflecting the prevalence described in the literature. GADA and IA-2A were not found in our children; this observation is in agreement with data showing that type 1 diabetes risk may not be altered by vaccinations administered during childhood. On the contrary, a high frequency (30%) of autoantibodies, in particular SMA, was observed in the nonresponder children. The 3 SMA-positive children carried the HLA-C4Q0,DRB1*0301,DQB1*02 haplotype, a well-known predisposing factor for autoimmune disorders. On the other hand, the presence of autoantibodies to smooth muscle is known to be common in hepatitis B infection, and, it has been shown that cross-reactive immunity targeting homologous self-protein may partly account for autoantibody production. Although hepatitis B vaccination given during the neonatal period does not increase autoantibody production in 6-year-old immunized children, we deem useful a more prolonged follow-up for these nonresponder children carrying certain HLA haplotypes (such as C4AQ0,DRB1*0301,DQB1*02), particularly because most autoimmune diseases do not develop until later in life.<\/jats:p>","DOI":"10.1542\/peds.110.1.e4","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"e4-e4","source":"Crossref","is-referenced-by-count":18,"title":["No Evidence of Autoimmunity in 6-Year-Old Children Immunized at Birth With Recombinant Hepatitis B Vaccine"],"prefix":"10.1542","volume":"110","author":[{"given":"Cesare","family":"Belloni","sequence":"first","affiliation":[{"name":"Division of Neonatal Intensive Care, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Avanzini","sequence":"additional","affiliation":[{"name":"Research Laboratory for Pediatric Oncohematology and Immunology, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[{"name":"Biometric Unit, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miryam","family":"Martinetti","sequence":"additional","affiliation":[{"name":"Immunohematology and Transfusional Center, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Pasi","sequence":"additional","affiliation":[{"name":"Immunohematology and Transfusional Center, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Coslovich","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Chemistry, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Autelli","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Chemistry, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Masanti","sequence":"additional","affiliation":[{"name":"Institute of Obstetrics and Gynecology, University of Pavia, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaclara","family":"Cuccia","sequence":"additional","affiliation":[{"name":"Department of Genetics and Microbiology, University of Pavia, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Tinelli","sequence":"additional","affiliation":[{"name":"Biometric Unit, IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Rondini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pavia, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Lorini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Genova, Gaslini Institute, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2002,7,1]]},"reference":[{"key":"2021121006202993400_R1","doi-asserted-by":"crossref","unstructured":"Cohen AD, Schoenfield Y. Vaccine-induced autoimmunity. J Autoimmun.1996;9:699\u2013703","DOI":"10.1006\/jaut.1996.0091"},{"key":"2021121006202993400_R2","doi-asserted-by":"crossref","unstructured":"Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ.1990:301:345","DOI":"10.1136\/bmj.301.6747.345"},{"key":"2021121006202993400_R3","doi-asserted-by":"crossref","unstructured":"Tudela P, Marti S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron.1992;62:236","DOI":"10.1159\/000187043"},{"key":"2021121006202993400_R4","doi-asserted-by":"crossref","unstructured":"Marshall E. A shadow falls on hepatitis B vaccination effort. Science.1998;281:630\u2013631","DOI":"10.1126\/science.281.5377.630"},{"key":"2021121006202993400_R5","doi-asserted-by":"crossref","unstructured":"Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity\u2014\u2018 vaccinosis\u2019: a dangerous liaison?J Autoimmun.2000;14:1\u201310","DOI":"10.1006\/jaut.1999.0346"},{"key":"2021121006202993400_R6","doi-asserted-by":"crossref","unstructured":"Hogenesh H, Azcona-Olivera J, Scott-Montcrieff C, Snyder P, Glickman LT. Vaccine-induced autoimmunity in the dog. Adv Vet Med.1999;41:733\u2013747","DOI":"10.1016\/S0065-3519(99)80056-1"},{"key":"2021121006202993400_R7","doi-asserted-by":"crossref","unstructured":"Curtis HA, Singh T, Newkirk MM. Recombinant cytomegalovirus glycoprotein gB (UL55) induces an autoantibodies response to the U1\u201370 kDa small nuclear ribonucleoprotein. Eur J Immunol.1999;29:3643\u20133653","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3643::AID-IMMU3643>3.0.CO;2-J"},{"key":"2021121006202993400_R8","doi-asserted-by":"crossref","unstructured":"Lindberg B, Ahlfors K, Carlsson A, et al. Previous exposure to measles, mumps, and rubella\u2014but not vaccinated during adolescence\u2014 correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics.1999;104(1). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/104\/1\/e12","DOI":"10.1542\/peds.104.1.e12"},{"key":"2021121006202993400_R9","doi-asserted-by":"crossref","unstructured":"Confavreux C, Suissa M, Saddier P, et al. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med.2001;344:319\u2013326","DOI":"10.1056\/NEJM200102013440501"},{"key":"2021121006202993400_R10","doi-asserted-by":"crossref","unstructured":"Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med.2001;344:327\u2013332","DOI":"10.1056\/NEJM200102013440502"},{"key":"2021121006202993400_R11","doi-asserted-by":"crossref","unstructured":"Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol.1989;44:93\u2013151","DOI":"10.1016\/S0065-2776(08)60641-0"},{"key":"2021121006202993400_R12","doi-asserted-by":"crossref","unstructured":"Martini A, Lorini R, Zanaboni D, Ravelli A, Burgio GR. Frequency of autoantibodies in normal children. Am J Dis Child.1989;143:493\u2013496","DOI":"10.1001\/archpedi.1989.02150160123025"},{"key":"2021121006202993400_R13","doi-asserted-by":"crossref","unstructured":"Martinetti M, De Silvestri A, Belloni C, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol.2000;97:234\u2013240","DOI":"10.1006\/clim.2000.4933"},{"key":"2021121006202993400_R14","doi-asserted-by":"crossref","unstructured":"Chirico G, Belloni C, Gasparoni A, et al. Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers. Pediatrics.1993;92:717\u2013719","DOI":"10.1542\/peds.92.5.717"},{"key":"2021121006202993400_R15","doi-asserted-by":"crossref","unstructured":"Vitali L, De Amici M, d\u2019Annunzio G, Martinetti M, Alibrandi A, Lorini R. Low serum TNF-a level in subjects at risk for type 1 diabetes. J Pediatr Endocrinol Metab.2000;13:475\u2013481","DOI":"10.1515\/JPEM.2000.13.5.475"},{"key":"2021121006202993400_R16","doi-asserted-by":"crossref","unstructured":"Lorini R, Avanzini MA, Lenta E, Cotellessa M, De Giacomo C, d\u2019 Annunzio G. Antibodies to tissue transglutaminase C in newly diagnosed and long-standing type 1 diabetes mellitus. Diabetologia.2000;43:815\u2013816","DOI":"10.1007\/s001250051381"},{"key":"2021121006202993400_R17","doi-asserted-by":"crossref","unstructured":"Whitacre CC, Reingold SC, O\u2019Looney PA, et al. A gender gap in autoimmunity. Science1999;283:1277\u20131278","DOI":"10.1126\/science.283.5406.1277"},{"key":"2021121006202993400_R18","doi-asserted-by":"crossref","unstructured":"Martin WJ, Martin SE. Naturally occurring cytotoxic anti-tumour antibodies in sera of congenitally athymic (nude) mice. Nature.1974;249:564\u2013565","DOI":"10.1038\/249564a0"},{"key":"2021121006202993400_R19","doi-asserted-by":"crossref","unstructured":"Cunningham AJ. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature.1974;252:749\u2013751","DOI":"10.1038\/252749a0"},{"key":"2021121006202993400_R20","doi-asserted-by":"crossref","unstructured":"Hardy RR, Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol.1994;55:297\u2013339","DOI":"10.1016\/S0065-2776(08)60512-X"},{"key":"2021121006202993400_R21","doi-asserted-by":"crossref","unstructured":"Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol.1998;16:545\u2013568","DOI":"10.1146\/annurev.immunol.16.1.545"},{"key":"2021121006202993400_R22","doi-asserted-by":"crossref","unstructured":"Hayakawa K, Asano M, Shinton SA, et al. Positive selection of natural autoreactive B cells. Science.1999;285:113\u2013116","DOI":"10.1126\/science.285.5424.113"},{"key":"2021121006202993400_R23","doi-asserted-by":"crossref","unstructured":"Marseglia GL, Alibrandi A, d\u2019Annunzio G, et al. Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine.2000;19:680\u2013683","DOI":"10.1016\/S0264-410X(00)00268-1"},{"key":"2021121006202993400_R24","unstructured":"Greco L, Maki M, Di Donato F, Visakorpi JK. Epidemiology of celiac disease in Europe and the Mediterranean area. In: Auricchio S, Visakorpi JK, eds. Common Food Intolerance I Epidemiology of Celiac Disease. Basel, Switzerland: Karger; 1992;2:25\u201344"},{"key":"2021121006202993400_R25","doi-asserted-by":"crossref","unstructured":"Catassi C, Ratsch IM, Fabiani E, et al. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies. Acta Paediatr.1995;84:672\u2013676","DOI":"10.1111\/j.1651-2227.1995.tb13725.x"},{"key":"2021121006202993400_R26","doi-asserted-by":"crossref","unstructured":"DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics.2001:108(6). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/108\/6\/e112","DOI":"10.1542\/peds.108.6.e112"},{"key":"2021121006202993400_R27","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D. Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol.1999;162:1802\u20131810","DOI":"10.1016\/S0168-8278(98)80740-X"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/1\/e4\/1115393\/pe07020000e4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/1\/e4\/1115393\/pe07020000e4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:21:07Z","timestamp":1639146067000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/110\/1\/e4\/64085\/No-Evidence-of-Autoimmunity-in-6-Year-Old-Children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,7,1]]},"published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.110.1.e4","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}